Keenova publishes Acthar Gel real-world study in severe autoimmune diseases

Company-sponsored chart review in a peer-reviewed journal examined physician-reported use and outcomes in rheumatoid arthritis, systemic lupus erythematosus, and dermatomyositis/polymyositis.

Summary

verifying reliability

Terms & Concepts

No specialized terms available for this topic.